EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Protocol for a systematic review and meta‐analysis of experimental models of amyotrophic lateral sclerosis

J. M. Gregory, F. M. Waldron, T. Soane, L. Fulton, D. Leighton, J. Chataway, S. Pal, S. Chandran, M. R. Macleod

Evidence-based Preclinical Medicine · 2016

DOI: 10.1002/ebm2.23 ↗
AstrattDettalji biblijografiċi

Astratt

Amyotrophic lateral sclerosis ( ALS ) is a rapidly progressive neurodegenerative disease with no cure and limited treatment options. There is therefore an urgent need for effective therapeutic interventions in this disease. This protocol outlines the strategy for a systematic review and meta‐analysis to identify, from in vivo animal and human induced pluripotent stem cell ( hiPSC ) studies, potential therapeutic interventions for ALS . Our aim is to perform a comprehensive review of the ALS literature to compile a list of (1) candidate interventions and (2) target pathways that may be of therapeutic benefit in patients with ALS .

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →